Moneycontrol PRO
Advertisement
HomeNewsSun pharmaceutical industries

Sun Pharmaceutical Industries

Jump to
  • shahid

    shahid

    "Markets continued to be buoyant on expectation of rate cut by RBI and positive global cues. We are seeing continuation of rally in the rate sensitive sectors led by reality, banks and FMCG which were also supported by budget related sops," said Vinod Nair, Head of Research, Geojit BNP Paribas Financial Services Ltd.

  • Prefer SKS Micro: Sudarshan Sukhani

    Prefer SKS Micro: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may prefer SKS Microfinance.

  • Buy Sun Pharma, target Rs 800: Chandan Taparia

    Buy Sun Pharma, target Rs 800: Chandan Taparia

    Chandan Taparia, Derivative & Technical Analyst at Anand Rathi Securities recommends buying Sun Pharmaceutical Industries with a target of Rs 800.

  • Six in Sixty: Stocks you should keep on your radar

    Six in Sixty: Stocks you should keep on your radar

    CNBC-TV18's Ekta Batra lists six stocks that you should focus on.

  • Advertisement
  • Advertisement
  • Advertisement
  • Advertisement
  • Mkts in risk-off mode; Nifty to hold 7500: PhillipCapital

    Mkts in risk-off mode; Nifty to hold 7500: PhillipCapital

    Vineet Bhatnagar of PhillipCapital says investors should use the current market weakness to buy stocks.

Advertisement
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347